Paragon Bioservices is a private-equity backed contract development and manufacturing organization (CDMO) whose focus is the development and manufacturing of biopharmaceuticals—including the production and purification of monoclonal antibodies, recombinant proteins, viral vectors and vaccines. The company provides research services, process development and cGMP manufacturing. Paragon's cGMP facilities include microbial and mammalian suites, fill-finish and fully-segregated virus facilities.
Responsibility to our clients, a passion for science and our collective need to contribute to better public health—that’s what keeps us motivated and excited about the work that we perform. We are driven by our commitment to provide exceptional quality, scientific excellence and superior customer service.
With 25 years in the business, Paragon’s multidisciplinary team of scientists, engineers, quality systems personnel and project managers have many years of experience working with biologics—from research and process development services to GMP manufacturing for clinical trials and eventual commercial launch.